Literature DB >> 22699944

[Epidemiology of ocular involvement in Adamantiades-Behçets disease].

C E Kneifel1, A-K Köhler, A Altenburg, C C Zouboulis, L Krause.   

Abstract

Epidemiological studies demonstrate a prevalence of Adamantiades-Behçets disease (MAB) in the range of 0.12-420 per 100,000 inhabitants with the highest rates in Istanbul, Turkey and the lowest rates in the USA. Ophthalmological data on the prevalence of ocular involvement are limited for MAB in Germany because most epidemiological studies are based on rheumatological or dermatological data. Berlin is the city with the highest number of non-native German inhabitants and its multiethnic character renders it uniquely appropriate for epidemiological studies on MAB. This article summarizes the most important epidemiological data of 140 patients (63 female and 77 male) with a mean follow-up of 6.4 years (range 0.5-22 years) which we have recently published. The mean age was 23 years at the first manifestation and 32 years when the fully developed disease was recorded. The mean age at onset of ocular involvement was 30 years, 56% of patients developed ocular involvement, which was the first manifestation in 8.6% and the second manifestation in 19.3%. More than half the patients developed ocular involvement. The calculated prevalence of ocular involvement in MAB is 1.77/100,000 inhabitants for the population of Berlin.

Entities:  

Mesh:

Year:  2012        PMID: 22699944     DOI: 10.1007/s00347-011-2503-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  30 in total

1.  Clinical manifestations and course of 200 Japanese patients with Behçet's disease.

Authors:  C Tanaka; T Matsuda; E Hayashi; Y Imamura; S Ozaki
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

2.  Recent epidemiological data on Behçet's disease in Iran. The 2001 survey.

Authors:  F Shahram; F Davatchi; A Nadji; A Jamshidi; H Chams; C Chams; N Shafaie; M Akbarian; F Gharibdoost
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

3.  Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey.

Authors:  N G Papoutsis; M B Abdel-Naser; A Altenburg; H Orawa; I Kötter; L Krause; U Pleyer; D Djawari; R Stadler; U Wollina; P K Kohl; H P M Gollnick; W Kirch; F R Ochsendorf; W Keitel; P Martus; C C Zouboulis
Journal:  Clin Exp Rheumatol       Date:  2006 Sep-Oct       Impact factor: 4.473

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  [Behçet disease in Turkey].

Authors:  T Saylan; G Ozarmagan; G Azizlerli; C Ovül; N Oke
Journal:  Z Hautkr       Date:  1986-08-01

Review 6.  [Adamantiades-Behcet's disease].

Authors:  L Krause
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

7.  Epidemiological features and visual prognosis of Behçet's disease.

Authors:  K Ando; Y Fujino; K Hijikata; Y Izawa; K Masuda
Journal:  Jpn J Ophthalmol       Date:  1999 Jul-Aug       Impact factor: 2.447

8.  Comparison of patients with Behçet's disease in the 1980s and 1990s.

Authors:  Atsushi Yoshida; Hidetoshi Kawashima; Yuta Motoyama; Hirobumi Shibui; Toshikatsu Kaburaki; Kazuyuki Shimizu; Kazuhiko Ando; Kiyono Hijikata; Yasuho Izawa; Kiyofumi Hayashi; Jiro Numaga; Yujiro Fujino; Kanjiro Masuda; Makoto Araie
Journal:  Ophthalmology       Date:  2004-04       Impact factor: 12.079

Review 9.  The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.

Authors:  S Mishima; K Masuda; Y Izawa; M Mochizuki; K Namba
Journal:  Trans Am Ophthalmol Soc       Date:  1979

Review 10.  Number VII Behçet's disease (Adamantiades syndrome).

Authors:  M Escudier; J Bagan; C Scully
Journal:  Oral Dis       Date:  2006-03       Impact factor: 3.511

View more
  2 in total

1.  [Differential diagnosis of anterior uveitis].

Authors:  S Thurau; U Pleyer
Journal:  Ophthalmologe       Date:  2016-10       Impact factor: 1.059

Review 2.  [Human leukocyte antigen (HLA) system in ophthalmology].

Authors:  T Lapp; D Reinhold; D Böhringer; T Reinhard
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.